|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-03-11 Purchase |
2004-03-11 6:51 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 2,000 | $24.89 | $49,778 | 15,000 (Direct) | View |
| 2003-12-05 Purchase |
2003-12-05 7:37 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 2,000 | $25.4 | $50,800 | 13,000 (Direct) |
View |
| 2003-08-14 Purchase |
2003-08-14 6:49 pm |
ICN PHARMACEUTICALS INC | ICN | BAILEY BARY (EVP & CFO) | 1,000 | $15.14 | $15,140 | 11,000 (Direct) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2006-08-31 Option Award | 2006-09-01 3:29 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 40 | $19.66 | $786 | 180 (Direct) |
View |
| 2006-06-01 Option Award |
2006-06-05 4:44 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 44 | $17.61 | $775 | 140 (Direct) | View |
| 2006-03-30 Option Award | 2006-04-03 5:51 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 49 | $15.86 | $777 | 96 (Direct) | View |
| 2005-12-01 Option Award | 2005-12-05 12:41 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 47 | $16.46 | $774 | 47 (Direct) | View |
| 2005-11-01 Option Award | 2005-11-03 5:48 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 10,000 | $0 | $0 | 26,446 (Direct) |
View |
| 2004-05-10 Other | 2004-05-11 7:21 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 1,446 | $14.69 | $21,242 | 16,446 (Direct) |
View |
| 2003-11-12 Equity Swap | 2003-11-14 12:34 pm | CLC HEALTHCARE INC | CLCE | BAILEY BARY (Director) | 21,000 | $1 | $21,000 | 0 (Direct) |
View |
| Transaction & Date |
Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2006-10-31 Option Award |
2006-11-02 5:26 pm |
2007-10-31 2016-10-31 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 5,353 | $18.68 | 5,353 (Direct) |
View |
| 2006-10-31 Option Award | 2006-11-02 5:26 pm | 2007-10-31 2016-10-31 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 94,647 | $18.68 | 94,647 (Direct) |
View |
| 2005-11-01 Option Award |
2005-11-03 5:48 pm | 2006-11-01 2015-11-01 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 5,643 | $17.72 | 5,643 (Direct) | View |
| 2005-11-01 Option Award |
2005-11-03 5:48 pm | 2006-11-01 2015-11-01 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 114,357 | $17.72 | 114,357 (Direct) | View |
| 2004-11-26 Option Award | 2004-11-30 12:03 pm |
2008-11-26 2014-11-26 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 4,180 | $23.92 | 4,180 (Direct) | View |
| 2004-11-26 Option Award |
2004-11-30 12:03 pm | 2005-11-26 2014-11-26 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 135,820 | $23.92 | 135,820 (Direct) |
View |
| 2003-11-04 Option Award |
2003-11-06 7:41 pm |
2004-11-04 2013-11-04 |
ICN PHARMACEUTICALS INC | ICN | BAILEY BARY (EVP & CFO) | 218,000 | $18.55 | 218,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 09 Jan 2009 03:23:16 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |